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ABSTRACT 21 
 This work reports the physico-chemical characterization of 21 exopolysaccharides 22 
(EPS) produced by Lactobacillus and Bifidobacterium strains isolated from the human 23 
intestinal microbiota, as well as the growth and metabolic activity of the EPS-producing 24 
strains in milk. The strains belong to the species Lactobacillus casei, Lactobacillus 25 
rhamnosus, Lactobacillus plantarum, Lactobacillus vaginalis, Bifidobacterium animalis, 26 
Bifidobacterium longum and Bifidobacterium pseudocatenulatum. The molar mass 27 
distribution of EPS fractions showed two peaks of different sizes, which is a feature shared 28 
with some EPS from bacteria of food origin. In general, we have detected an association 29 
between the EPS-size distribution and the EPS-producing species, although due to the low 30 
number of human bacterial EPS tested we cannot establish a conclusive correlation. The main 31 
monosaccharide components of the EPS under study were glucose, galactose and rhamnose, 32 
which are the same than those found in food polymers; however rhamnose and glucose ratios 33 
was generally higher than galactose in our human bacterial EPS. All EPS-producing strains 34 
were able to grow and acidify milk; most lactobacilli produced lactic acid as the main 35 
metabolite. The ratio lactic/acetic acid in bifidobacteria was 0.7, close to the theoretical one, 36 
indicating that they did not produce an excessive amount of acetic acid that could adversely 37 
affect the sensory properties of fermented milks. With respect to the viscosifying ability, L. 38 
plantarum H2 and L. rhamnosus E41 and E43R were able to increase the viscosity of stirred 39 
fermented milks at a similar extent to the EPS-producing Streptococcus thermophilus strain 40 
used as positive control. Therefore, these human EPS-producing bacteria could be used as 41 
adjuncts in mixed cultures for the formulation of functional foods if probiotic characteristics 42 
were demonstrated. This is the first article reporting the physico-chemical characteristics of 43 
EPS isolated from human intestinal microbiota.  44 
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INTRODUCTION 48 
 Recently, the concept of “functional starter” has been introduced referring to 49 
“cultures that posses properties which contribute to food safety and / or offer one or more 50 
organoleptic, technological, nutritional, or health advantages” (Leroy and De Vuyst, 2004). In 51 
this context, some exopolysaccharide (EPS)-producing lactic acid bacteria (LAB) strains 52 
could cover both technological and health aspects. Their capability to improve the rheological 53 
characteristics of fermented milks has been proven and, more recently, health benefits have 54 
been attributed to some of these biopolymers. It is well known that the key parameters 55 
determining the viscosity and texture intensifying capability of EPS are mainly their chemical 56 
composition, molar mass and the structure of the repeating units (Laws and Marshall, 2001) 57 
as well as their interaction with the food protein matrix (Hassan, 2008). However, there are 58 
very few articles reporting the relationship between the physico-chemical characteristics of 59 
EPS and their putative health promoting properties (Nagaoka et al., 1994; Kitazawa et al., 60 
1998). These studies have been conducted with polymers synthesized by food origin LAB, 61 
and as far as we know no data are available about the physico-chemical characteristics of 62 
polymers isolated from human origin strains. Indeed, these strains could be good candidates 63 
to study the relationship between the EPS production phenotype and its putative involvement 64 
in their probiotic properties. In this way, we have demonstrated that human isolated 65 
Lactobacillus and Bifidobacterium strains are able to produce EPS (Ruas-Madiedo et al., 66 
2007). 67 
 Nowadays, fresh fermented and unfermented dairy products, such as milk, yogurt, 68 
ice cream and desserts are widely employed for the delivery of probiotic strains and the 69 
incorporation into cheeses is under development (Boylston et al., 2004; Grattepanche et al., 70 
2008). The viability of probiotics in fermented milks has improved in recent years but this 71 
was to the detriment of the variability of strains employed in the formulation of these foods 72 
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(Gueimonde et al. 2004). These strains have been selected as they have been shown to survive 73 
well in the fermented product but their health promoting properties have not been taken into 74 
account. Thus, the exploration of both technological and probiotic properties is crucial for the 75 
potential application of new strains in functional food formulations.  76 
 In the current work, we aimed to study the growth and metabolic activity of human 77 
isolated EPS-producing strains in milk. This characterization could allow us to identify 78 
potential probiotic strains with appropriate technological properties for dairy applications. 79 
Indeed, in a previous work we have shown that the EPS produced by these Bifidobacterium 80 
strains had the ability to modulate the intestinal microbiota, promoting a bifidogenic effect 81 
comparable to that of the prebiotic inulin (Salazar el al., 2008). Thereby, the physico-chemical 82 
characteristics of EPS synthesized by these strains have been analyzed in order to establish a 83 
preliminary classification of these biopolymers based on their molar mass and 84 
monosaccharide composition. This could help us in a future to correlate the intrinsic 85 
characteristics of EPS with their putative health benefits.  86 
 87 
MATERIAL AND METHODS  88 
Bacterial Strains and Isolation of EPS Fraction from Culture Media 89 
The human-origin strains employed in this study (Table 1) have been previously 90 
screened for EPS production and they were identified by 16S rRNA gene sequencing (Ruas-91 
Madiedo et al., 2007). Strains were grown in MRSC broth [MRS (BioKar Diagnostics, 92 
Beauvais, France) supplemented with 0.25% (wt/vol) L-cysteine (Sigma Chemical Co., St. 93 
Luis, MO)] and incubated at 37ºC for 24 h under anaerobic conditions as previously described 94 
(Salazar et al., 2008). The strain Streptococcus thermophilus ST-body-1 (Chr. Hansen, 95 
Horsholm, Denmark), currently employed in yoghurt manufacture, was used as an EPS-96 
producing positive control. This control strain was directly inoculated from the lyophilized 97 
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powder into M17 broth (Oxoid Ltd., Basingstoke, Hampshire, UK) and grown overnight at 98 
37ºC. This culture was employed to inoculate (2%) fresh M-17 broth which was incubated 99 
during 24 h. 100 
 The EPS fraction of strains was isolated from the cellular biomass harvested from 101 
agar-MRSC plates. In short, strains were grown on the surface of agar-MRSC for 5 days 102 
under anaerobic conditions at 37ºC. Cellular biomass was collected with ultrapure water and 103 
mixed with 1 vol of 2 M NaOH. After gently stirring overnight at room temperature, cells 104 
were removed by centrifugation and EPS from the supernatants were precipitated for 48 h at 105 
4ºC using 2 vol of absolute cold ethanol. After centrifugation, the EPS fraction was 106 
resuspended in ultrapure water, dialyzed against ultrapure water for 3 days at 4ºC in dialysis 107 
tubes (Sigma) of 12 to 14 kDa molecular mass cut off and finally freeze-dried.  108 
Molar Mass Distribution of EPS Fractions  109 
 Size exclusion chromatography (SEC) was employed to determine the molar mass 110 
(MM) distribution of the EPS fractions. The lyophilized fractions were resuspended (5 111 
mg/mL) in 0.1 M NaNO3, kept overnight under gently stirring, and finally centrifuged 112 
(10000g, 10 min) before analysis. A HPLC chromatographic system composed of an Alliance 113 
2690 module injector, a Photodiode Array PDA 996 detector, a 410 refractive index (RI) 114 
detector and the Empower software (Waters, Milford, MA, USA) was used. The separation 115 
(50 L vol injection sample) was carried out in two columns placed in series, TSK-Gel G3000 116 
PWXL + TSK-Gel G5000 PWXL protected with a TSK-Gel guard column (Supelco-Sigma). 117 
The mobile phase was 0.1 M NaNO3 and the separations took place at 40ºC at a flow rate of 118 
0.45 mL/min. The EPS peaks were detected with the RI detector and the presence of proteins 119 
was monitored through the PDA detector set at 220 nm. Standards of dextran (Fluka-Sigma), 120 
ranging from 5x10
3
 to 4.9x10
6
 Da, were used for quantification and MM determination. For 121 
quantification, the corresponding regression equations were calculated from four different 122 
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concentrations of each standard (R
2
 0.98) and for the MM determination the regression 123 
equation was calculated using the elution time of seven dextran standards of different MM ( 124 
R
2
 =0.99). The peaks obtained after SEC were arbitrarily distributed amongst four molar mass 125 
ranges. The percentage of each peak was calculated with respect to the total amount of peaks 126 
detected in each EPS fraction (g peak range x 100)/ (g total peaks).  127 
Monosaccharide Composition of EPS Fractions  128 
 The EPS fractions were hydrolyzed with 0.15, 1.5 or 3 M trifluoroacetic acid for 1 h at 129 
121ºC. The products were converted into their corresponding alditol acetates and then identified 130 
and quantified by gas-liquid chromatography (GLC), with inositol as the internal standard (IS). 131 
The neutral sugars composition was determined in an Autosystem instrument (Perkin Elmer, 132 
Norwalk, CT, USA) equipped with a flame ionization detector, using a TR-CN100 capillary 133 
column (30 m x 0.25 mm, 0.2 m film thickness) and a temperature program from 210ºC (1 134 
min) to 240ºC (ramp rate of 15ºC per min, final temperature during 7 min) employing He as gas 135 
carrier. Injection was performed in the split mode (split ratio 50:1). The percentage of each 136 
monosaccharide was calculated with respect to the total monosaccharide content. For amino-137 
sugars identification, sample components were analyzed by GC-MS in an Agilent 7980A-5975C 138 
instrument (Agilent Technologies Inc., Palo Alto, CA, USA), using a HP-5 column (30 m x 0.25 139 
mm, 0.2 m film thickness) and a temperature program  of 170 to 210ºC, 1 min initial hold, 2 ºC 140 
per min ramp rate. Peaks were identified on the basis of the sample coincidence with relative 141 
retention times of commercial standards and by their mass spectra.  142 
Growth of EPS-producing Strains in Milk 143 
 Commercial pasteurized milk (Central Lechera Asturiana, Asturias, Spain) was 144 
purchased from the supermarket and was supplemented with 1% Difco skimmed milk 145 
(Becton Dickinson, MD, USA) and 0.2% yeast extract (Biokar) giving a total solid content of 146 
12.5%. This supplemented milk was pasteurized again at 90ºC during 5 min.  MRSC or M17 147 
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cultures of each strain were washed twice with sterile PBS buffer pH 7.0 and were separately 148 
employed to inoculate (2%) 500 mL of pasteurized milk. The inoculated milks were incubated 149 
overnight (17± 1 h) in a water bath at 37ºC and, at the end, a sample was collected in sterile 150 
conditions for bacterial counting and pH measurements. Afterwards, the fermented milks 151 
were cool-down to approximately 18ºC with running tap water, then they were stirred 20-152 
times up and down with a spoon and stored overnight at 4ºC. Three replicated batches of 153 
fermented milks were carried out for each strain.  154 
 For bacterial counts, serial dilutions of cultured milks were made in Ringer’s solution 155 
(Merck, Darmstadt, Germany) and deep-plated on agar-MRSC or agar-M17. The plates were 156 
incubated at 37ºC during 3 days under anaerobic conditions for Lactobacillus and 157 
Bifidobacterium and under aerobic conditions for S. thermophilus. Counts were expressed as 158 
Log cfu/g and the increase of the Log units during milk fermentation was calculated.  159 
 160 
Isolation of EPS from Cultured Milk and Apparent Viscosity of Stirred-Fermented 161 
Milks 162 
 The EPS fraction was isolated from milks cultured with the human origin EPS-163 
producing strains. Briefly, 40 g of cultured milk was mixed with TCA solution (12% final 164 
concentration) and strongly stirred for 45 min at room temperature. Precipitated bacteria and 165 
proteins were removed by centrifugation (10000g, 4ºC, 30 min) and the pH of supernatant 166 
was raised to 4.5±0.5. Finally, supernatants were intensively dialyzed and freeze-dried as 167 
described in the previous paragraph. Given that the yeast extract added to milk could be a 168 
source of polysaccharides (mainly gluco- and galacto-mannans), the same procedure was 169 
employed to obtain the precipitated-fraction of uncultured supplemented pasteurized milk. 170 
The EPS yield (mg/100 mL of whey) of each strain growing in milk was calculated after 171 
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subtracting the precipitated-fraction (15.0±1.5 mg/100 mL of whey) obtained from the 172 
uncultured milk.  173 
 The apparent viscosity of stirred-fermented milks was measured using the Posthumus 174 
funnel (Hellinga et al., 1989). The funnel was filled with approximately 450 g of stirred-175 
fermented milk and the time (s) taken to pass the mark inside the funnel was recorded. The 176 
measurements were carried out in a chamber refrigerated at 4ºC. 177 
Lactose Consumption and Organic Acids Production in Fermented Milks 178 
 The same HPLC chromatographic system described before was employed to quantify 179 
the lactose consumption and organic acid production in fermented milks. Samples for HPLC 180 
analysis were prepared as follows: 5 g of cultured milk was mixed with 20 mL of 9 mN 181 
H2SO4, kept at 37ºC with constant shaking for 2 h and, after centrifugation (10000g, 20 min), 182 
supernatants were filtered through filter paper. The sample separation was carried out in an 183 
ICSep ION-300 ion-exchange column (Transgenomic, San Jose, CA, USA) using 8.5 mN 184 
H2SO4 as mobile phase at 65ºC and with a flow rate of 0.4 mL/min.  Lactose was detected by 185 
using the RI detector and the organic acids by using the PDA detector set at 210 nm. For 186 
quantification, the regression equations (R
2
 0.99) were calculated using different 187 
concentrations of the corresponding standards purchased from Fluka-Sigma. Results were 188 
expressed as mM.  189 
Production of Volatile Compounds in Fermented Milks 190 
 Volatile compounds produced by lactobacilli and bifidobacteria in fermented milks 191 
were determined by means of head-space (HS) GC-MS. Samples (10 g) of fermented milk 192 
were mixed with cyclohexanone (0.36 mg/mL) as IS and were placed into glass tubes sealed 193 
with rubber and metallic caps. They were analyzed in a 6890N Agilent GC coupled with a HS 194 
automatic injector G1888 series and with a 5975B inert MS detector (Agilent). Data was 195 
collected and analyzed with the ChemStation software. Samples in the HS were kept at 50ºC 196 
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during 30 min under stirring and then separated in a HP-Innovax column (60 m x 0.25 mm x 197 
0.25 m film thickness, Agilent). The temperature of the injector was kept at 220ºC and the 198 
split ratio was 20:1. The chromatographic conditions were 35ºC during 5 min, 100ºC (ramp 199 
ratio 5ºC per min) final temperature during 10 min, 240ºC (ramp ratio 8ºC per min) final 200 
temperature during 5 min, using He as gas carrier. The electron impact energy of the MS 201 
detector was set to 70eV and data were collected within the 20 to 250 amu range (at 3.12 202 
scans/s). The volatile compounds were identified by comparing their mass spectra with those 203 
held in the Wiley 138 library (Agilent) and by comparing their retention times with those of 204 
the corresponding standards (Fluka-Sigma). The peaks were quantified as the relative total 205 
ionic count abundance with respect to the IS. The concentration (g/mL) of each volatile 206 
compound was calculated using linear regression equations (R
2 
>0.99) of the corresponding 207 
standards.  208 
 209 
RESULTS AND DISCUSSION 210 
Characterization of EPS Produced by Human Bifidobacterium and Lactobacillus Strains 211 
 A broad MM distribution, ranging from about 10
3
 to 5x10
6
 Da, of the EPS fractions 212 
isolated from agar-MRSC plates of Bifidobacterium and Lactobacillus strains from human 213 
intestinal origin was detected. In addition, within each EPS-fraction more than one peak 214 
varying in size was monitored (Table 1). Then, an arbitrary classification of MM ranges has 215 
been established as follows: M1: >10
6
 Da, M2: 10
5
-10
6
 Da, M3: 10
4
-10
5
 Da, and M4: <10
4
 216 
Da. Most EPS-fractions showed two different MM peaks and all of them included the smaller 217 
peak range, in some cases being present at the highest (more than 80%) proportion. The four 218 
Lactobacillus plantarum as well as Lactobacillus. casei BA61 and F72 strains showed a 219 
second peak within the M3 range. However, L. casei E51 was the only lactobacilli presenting 220 
a peak (2x10
6
 Da) of the highest M1, whereas in the two Lactobacillus rhamnosus strains and 221 
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the Lactobacillus vaginalis strain the M2 peak was detected. This data indicates a different 222 
pattern of EPS-MM distribution within each Lactobacillus species. Similar behavior was also 223 
noted for the Bifidobacterium species. Thus, the two Bifidobacterium animalis strains have 224 
EPS with a second peak in the M3 range; in 3 out of 4 Bifidobacterium. longum strains the 225 
M2 range was detected, and most Bifidobcterium pseudocatenulatum strains presented the M1 226 
highest range. However, the scarce number of strains analyzed for each species do not allow 227 
us to establish a definitive direct correlation between EPS-size distribution and the EPS-228 
producing species. As far as we are aware, there is no available data in the literature reporting 229 
the MM values of EPS synthesized by lactobacilli of human origin. Mozzi and co-workers 230 
(2006) collected data of EPS from several mesophilic and thermophilic Lactobacillus strains 231 
from food origin and most showed MM values lower than 10
6
 Da as it was evidenced in our 232 
human origin EPS-strains. But none of the food strains presented simultaneously more than 233 
one MM peak. However, the EPS-fraction produced by several strains of Lactobacillus 234 
delbrueckii subsp. bulgaricus, S. thermophilus and Lactococcus lactis subsp. cremoris as well 235 
as that synthesized by Lactobacillus pentosus LPS26 presented simultaneously two EPS of 236 
different MM (Grobben et al., 1997; Degeest and De Vuyst, 1999; Petry et al., 2003; 237 
Vaningelgem et al., 2004; Ruas-Madiedo et al., 2005; Sánchez et al., 2006). Thus, it seems 238 
that the production of two EPS peaks of different size is a relatively common characteristic 239 
among LAB from food and intestinal origin. With respect to the EPS synthesized by 240 
Bifidobacterium, scarce data is available in the literature regarding their MM distribution 241 
(Nagaoka et al., 1995; Roberts, 1995; Hosono et al., 1997). The production of two EPS-242 
fractions of different sizes has been detected as well in B. longum and Bifidobacterium 243 
infantis (Abbad-Andaloussi et al., 1995; Tone-Shimokawa et al., 1996). It has been reported 244 
that the variation in the culture conditions (nitrogen and carbon sources, pH, temperature, 245 
etc.) could modify the ratio of high to low MM (Degeest and De Vuyst, 1999) or might 246 
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induce the production of two EPS of a different chemical / structure composition (Cerning et 247 
al., 1994; Petry et al., 2000; Wang & Bi, 2008). It has been also postulated that the occurrence 248 
of more than one EPS fraction produced by a single strain could be due to a partial hydrolysis 249 
of the highest peak as a consequence of prolonged fermentations (De Vuyst et al., 1998). We 250 
can not discard a partial hydrolysis of our EPS after incubation of the producing bacteria in 251 
the surface of agar-MRSC for 5 days. In fact, we were able to cultivate in MRSC broth the 252 
biomass collected from solid medium after this period. However, part of the microbial 253 
population could have become not viable or even dead and thus releasing glycolytic enzymes. 254 
In spite of this, a relative long incubation period (5 days) has been used in our case due to the 255 
generally slow growth of strains from human origin and the need for obtaining optimal 256 
biomass production in order to provide enough EPS for their physico-chemical 257 
characterization.  258 
 Regarding the chemical composition (Table 1), the monosaccharides galactose and 259 
glucose were present in all polymers and rhamnose in half of them. These are also the three 260 
major sugar components of EPS isolated from food environments. Mannose, fucose and N-261 
acetyl-glucosamine were detected in minor proportions in 4 out of the 11 Bifidobacterium 262 
strains and L. vaginalis C32. N-acetyl-aminated sugars are also commonly found in EPS from 263 
LAB, whereas fucose and mannose have been described in only a few strains (Ruas-Madiedo 264 
et al., 2009). The ratio among the major monosaccharides varied depending on the strain and 265 
a species-associated pattern has not been evidenced for most of them. In general for all EPS, 266 
with the exception of the two B. animalis strains, galactose was present at a lower ratio than 267 
glucose and rhamnose, when this last monosaccharide was present. On the opposite, in EPS 268 
from lactobacilli of food origin galactose is often found at the same or higher proportion than 269 
the other monosaccharides (Mozzi et al., 2006; Ruas-Madiedo et al., 2009). In the EPS 270 
produced by our B. animalis and B. longum strains (with the exception of strain E44) from 271 
 13 
human origin the monosaccharide rhamnose was present, whereas in B. pseudocatenulatum it 272 
was absent. Even more, strains B. longum H73 and H67 presented a high content of rhamnose 273 
as it was also detected for the EPS from most L. casei and rhamnosus strains. In this respect, 274 
it is interesting to note that the polymer composition of 25 EPS produced by LAB strains from 275 
food revealed that only 7 (28%) had rhamnose in their composition (Ruas-Madiedo et al., 276 
2009). Whereas, the EPS produced by our strains of human origin presented higher rhamnose 277 
occurrence (11 out of 21 strains, 52%) and also higher proportion (ratio above 1). In this 278 
respect, the high rhamnose content of EPS from Bifidobacterium has been related with their 279 
capacity of protection against induced gastric ulcers in rats (Nagaoka et al., 1994). The 280 
chemical characterization of the human bacterial EPS carried out in this work confirmed our 281 
previous results relating the screening of genes involved in EPS synthesis (Ruas-Madiedo et 282 
al., 2007) which pointed out that they were heteropolysaccharides. Finally, it is necessary to 283 
be careful when using laboratory media for analyzing EPS produced by intestinal bacteria. In 284 
fact, environmental conditions of laboratory and gut are drastically different and it is known 285 
that culturing conditions have a major influence on the type of EPS produced. Hence 286 
differences in EPS maybe expected between that found in our study and that actually 287 
produced in the gut environment by the same strain.  288 
 289 
Growth and Metabolic Activity of Human Origin EPS-producing Strains in Milk  290 
 The EPS-producing strains isolated from human microbiota were grown in 291 
pasteurized milk supplemented with 0.2% of yeast extract which was added for increasing the 292 
available nitrogen source in order to allow these strains to grow in milk as single cultures. The 293 
pH values and the increase of the Log cfu/g after 17±1h of incubation at 37ºC are depicted in 294 
Figure 1. The initial pH of milk was 6.5±0.2 and all lactobacilli were able to decrease the pH 295 
below 4.5, except L. vaginalis C32 that only reached a value of 5.1. The pH of milks cultured 296 
 14 
with Bifidobacterium strains presented values around 4.5, with the exception of those of B. 297 
longum L55 and E44 that displayed lower values and those made with B. animalis C64MRa 298 
and E43 which were above 5.0. Regarding the ability to grow in milk, all bacteria increased 299 
their counts more than 1.5 Log cfu/g with respect to the initial levels. Among lactobacilli, L. 300 
casei strains reached the highest counts followed by L. rhamnosus and L. plantarum. 301 
Remarkably, several Bifidobacterium strains were able to increase their counts more than 2.5 302 
Log units. Contrary to that expected, B. animalis strains showed the poorest ability to grow in 303 
milk which was in accordance with their low capacity to produce organic acids.  304 
 Figure 2 shows the lactose consumption and organic acids production in milks 305 
fermented with the EPS-producing strains from human origin. Milks cultured with B. animalis 306 
C64MRa and E43 presented the lowest lactose consumption and consequently the lowest 307 
lactic and acetic acid production, as compared with the other strains. The initial lactose 308 
content in the pasteurized milk was 28.7±2.4 mM and the consumption ranged between 8% 309 
(for B. animalis E43) and 36% (for L. plantarum C64MRb) showing a wide variability among 310 
strains. The average lactic/acetic acid ratio obtained in these fermented milks was 0.85±0.14 311 
for Bifidobacterium and 4.51±1.12 for Lactobacillus. From a sensory point of view, the 312 
production of no excessive high amounts of acetic acid as compared with the lactic acid is a 313 
desirable characteristic for preserving the sensory properties of fermented milk. Ethanol was 314 
produced in variable amounts depending on the strain (Table 2). Acetaldehyde and diacetyl 315 
were also detected in most milks cultured with bifidobacteria. A moderate production of 316 
acetic acid and a very low level of ethanol were detected in milks fermented with L. casei, L. 317 
rhamnosus and L. plantarum groups with most glucose, coming from the hydrolysis of 318 
lactose, being converted into lactic acid. The strain L. vaginalis C32 had a different behavior, 319 
as it was the highest ethanol (277 g/mL on average) and the lowest lactic acid producer 320 
among lactobacilli which is in good accordance with the heterofermentative metabolism of 321 
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this species (Embely et al., 1989). The ability of our strains to grow in milk is strain-322 
dependent as it was previously indicated for other probiotic Bifidobacterium and 323 
Lactobacillus strains (Gilliland et al., 2002; Ostlie, et al., 2003). It is known that the milk 324 
composition influences the growth capacity of the strains (Kehagias et al., 2008). This could 325 
be related to the different amino acid availability among the milk types. Because in our case a 326 
fast-use nitrogen source (yeast extract) was available, other factors (such as variation in -327 
galactosidase activity, carbohydrate and peptide / amino acid transport systems, oxygen / pH 328 
tolerance, etc.) behind differences in proteolytic activity could account for the different 329 
capacity to grow in milk of our strains. Variations in the levels of metabolites produced 330 
during milk fermentation were also detected among our strains as other authors previously 331 
indicated (Baron et al., 2000; Ostlie et al., 2003). In this way, it is well known that the 332 
metabolic profile of potential probiotic strains growing in milk correlates directly with the 333 
sensory characteristics of the product, thereby being an important selection criterion for the 334 
formulation of functional dairy foods. Finally, this study was conducted to select strains with 335 
potential application for human consumption. However, since the yeast extract can not be 336 
included into the formulation of fermented milks, would be the use of starters (S. 337 
thermophilus and/or L. delbrueckii subsp. bugaricus) the next step in the assay of mixed 338 
fermentations for application in dairy industry.    339 
 The apparent (Posthumus) viscosity of milks cultured with some human EPS-340 
producing strains, as well as the amount of EPS-fraction purified from the fermented milks, is 341 
presented in Table 3. The amount of the EPS produced in milk by the strains under 342 
characterization was low. It is worthy to mention that this value could have been 343 
underestimated due to the subtraction of the precipitated fraction from the uncultured milk. 344 
However, this was necessary in order to avoid the quantification of possible polysaccharides 345 
coming from the small amount of yeast extract added to the milk that could be co-precipitated 346 
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during the EPS purification process. In general, the viscosity intensifying capability of the 347 
human origin strains was very scarce and most strains showed values of apparent viscosity 348 
lower than 35 s (data not shown). Only three of our lactobacilli strains conferred to the 349 
fermented milks a smooth and creamy consistency comparable to that of the EPS-producing 350 
S. thermophilus strain used as control (Table 3). These were L. rhamnosus E41 and E43R and 351 
L. plantarum H2. Interestingly, the same strains were also able to increase the apparent 352 
viscosity of the stirred fermented milks, although their values were lower than that of S. 353 
thermophillus ST-body-1. Among these three lactobacilli, only L. plantarum H2 increased the 354 
viscosity of the fermented milk by producing similar low EPS amount to those produed  by S. 355 
thermophilus, their yield being lower than that of L. rhamnosus E41 and E43R strains 356 
although their viscosity intensifying ability was higher. Other EPS intrinsic characteristics 357 
beyond the concentration reached in milk, could also account for the increase in viscosity of 358 
milks fermented with the human origin EPS-producing strains (Laws and Marshall, 2001). 359 
The MM of an EPS strongly influences the viscosity of fermented milks made with EPS-360 
producing strains and, in general, polymers having high MM can produce fermented milks 361 
with higher viscosity (Ruas-Madiedo et al., 2009). However, in the present study we can not 362 
correlate the MM values obtained in MRSC medium with the viscosity of the fermented milk 363 
because, as previously stated, MM and chemical composition of EPS could greatly vary 364 
depending on the culture conditions. Finally, factors such as interactions between the EPS and 365 
the milk protein network (Hassan et al., 2008) or the acidification rate of the strains in milk 366 
(Lucey and Singh, 1998), among others, could affect the viscosity of the stirred fermented 367 
milk. However, since our human origin strains E41, E43R and H2 and the control strain 368 
reached similar final pH after the same incubation period (3.82±0.08, 3.76±0.02, 3.88±0.09 369 
and 3.97±0.06, respectively) differences in acidification could have not account for variation 370 
in the viscosity of the fermented milks. 371 
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 372 
CONCLUSION  373 
 Our EPS-producing strains from human origin presented higher rhamnose content 374 
than strains of food origin previously studied by other authors. In a future this characteristic 375 
could be correlated with a putative biological effect at intestinal mucosa level. Nowadays, it is 376 
not possible to reproduce in the laboratory the gut conditions in order to be able to study the 377 
EPS production in this environment. Thereby, the use of laboratory media is a valuable 378 
technique to undertake the preliminary characterization of polymers from new origin. 379 
However, given the influence of the culturing conditions on both MM and chemical 380 
composition of EPS, the characterization of EPS produced in the gut environment remains as 381 
a challenge for the future. 382 
  For dairy industry applications, it is important to know the growth capability and the 383 
metabolic activity of these microorganisms in milk. Our study indicates that three EPS-384 
producing lactobacilli, L. rhamnosus E41, L. rhamnosus E43R, and mainly L. plantarum H2, 385 
could have good technological properties. They all grew and acidified milk and, additionally, 386 
they were able to increase the viscosity and to confer a desirable texture to the fermented 387 
product. Most bifidobacteria were able to grow and acidify milk without producing an 388 
excessive amount of acetic acid which would not be a desirable sensory characteristic in 389 
fermented milks. Therefore, both lactobacilli and bifidobacteria could be used as adjuncts in 390 
mixed cultures for the formulation of functional foods if they would present probiotic 391 
characteristics.  392 
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Table 1: Bifidobacterium and Lactobacillus strains of human origin and physico-chemical characteristics of their EPS fractions isolated from the 512 
cell biomass harvested from the surface of agar-MRSC plates. 513 
  EPS-fractions 
Species Strain  Molar mass (Da) distribution  (%)
1
  Monosaccharide Ratio
2
    Presence
3
 
   > 10
6 
 10
5
-10
6
 10
4
-10
5
 < 10
4 
  Ram Gal Glc  Other 
B. animalis  C64MRa  - - 9 91  1 1.5 2.5  - 
 E43  - - 12.3 87.7  1 2 2.5  Man 
B. longum H73  - 70.7 - 29.3  2 1 2.5  Fuc 
 L55  - 45.9 - 54.1  1 1 4  - 
 H67  - 52.6 - 47.4  4 1 4  Fuc 
 E44  11.1 - - 88.9   1 1  - 
B. pseudocatenulatum A102  40.6 - 22.7 36.7   1 2  - 
 C52  10.4 - - 89.6   1 1  Ram 
 E515  47.1 - - 52.9   1 2  - 
 E63  38.0 - - 61.9   1 1  - 
 H34  - 56.5 - 43.5   1 1.5  Fuc, NAGlc 
L. casei BA61  - - 55.4 44.6  2 1 4  - 
 E51  16.1 - - 83.9   1 2  - 
 F72  - - 58.9 41.1  2 1 2.4  - 
L. rhamnosus E41  - 76.9 - 23.1  3 1 3  - 
 E43R  - 55.9 - 44.1  4 1 2  - 
L. plantarum C64MRb  - - 18.4 81.6   1 9  - 
 E112  - - 7.5 92.5   1 5  - 
 G62  - - 11.3 88.7   1 5  - 
 H2  - - 32.3 67.7   1 3  Ram 
L. vaginalis C32  - 68.6 - 31.4   1 2  Man, NAGlc 
1
Percentage calculated with respect to the total amount (g) of peaks measured by GPC.  514 
2
Ram: rhamnose, Gal: galactose, Glc: glucose.  515 
3
Content lower than 10% of the total monosaccharides. Man: mannose, Fuc: fucose, NAGlc: N-acetyl-glucosamine.  516 
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Table 2: Volatile compounds produced in milks fermented with EPS-producing 517 
Bifidobacterium and Lactobacillus strains from human origin. 518 
  Mean ± SD (g /mL) 
Species Strain Acetaldehyde 
1
 Diacetyl Ethanol 
Uncultured milk - 0.27±0.06 0.19±0.01 2.17±0.04 
B. animalis  C64MRa 21.86±1.24 0.99±0.16 47.91±5.81 
 E43 ND 2.00±0.58 167.25±46.39 
B. longum H73 6.20±0.83 3.34±0.57 40.50±3.76 
 L55 10.04±1.54 1.75±0.20 43.00±3.61 
 H67 14.70±0.72 4.35±0.33 51.01±1.28 
 E44 7.67±0.93 1.22±0.01 37.43±4.05 
B. pseudocatenulatum A102 16.43±0.28 3.32±1.41 35.80±2.51 
 C52 12.35±5.78 2.41±0.21 31.75±0.88 
 E515 14.30±0.55 3.72±1.69 30.48±5.7 
 E63 ND 3.45±0.18 25.80±5.72 
 H34 11.48±5.74 5.96±3.42 30.75±12.15 
L. casei BA61 ND 0.08±0.01 18.37±0.43 
 E51 ND 1.35±0.30 35.32±0.70 
 F72 ND 0.19±0.12 9.45±1.45 
L. rhamnosus E41 ND 0.32±0.04 13.53±0.87 
 E43R ND 0.25±0.05 12.64±0.46 
L. plantarum C64MRb ND 0.31±0.10 4.09±1.53 
 E112 ND 0.54±0.34 11.59±0.19 
 G62 1.62±1.02 0.44±0.18 3.28±0.39 
 H2 ND 0.43±0.22 13.79±0.35 
L. vaginalis C32 ND 1.92±1.32 277.09±125.73 
S. thermophilus 
2
 St-body-1 9.38±0.56 0.75±0.11 4.92±0.79 
1
ND: level under detection limit 519 
2
The strain Streptococcus thermophilus ST-body-1 was used as EPS-producing strain 520 
control. 521 
522 
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Table 3: EPS production and apparent (Posthumus) viscosity of stirred milks fermented 523 
with some EPS-producing Lactobacillus strains from human origin.  524 
  Mean ± SD 
  Viscosity  EPS-fraction 
1
 
Species Strain (s)  (mg/100 mL whey) 
L. rhamnosus E41 63.3±3.7  29.0 
 E43R 69.0±7.9  51.4±11.4 
L. plantarum H2 72.0±24.0  18.9 
S. thermophilus 
2
 St-body-1 143.3±20.8  15.5±0.2 
1
The values were calculated after subtracting the precipitated-fraction isolated from 525 
non-fermented milk. 526 
 2
 Streptococcus thermophilus ST-body-1 was used as EPS-producing strain control with 527 
high viscosity intensifying capability.  528 
529 
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FIGURE LEGENDS 530 
Figure 1. pH values of milks fermented with EPS-producing Bifidobacterium and 531 
Lactobacillus strains from human origin and increase of the Log cfu/g after incubation 532 
at 37ºC during 17±1 h. The strain Streptococcus thermophilus ST-body-1, employed in 533 
yoghurt manufacture, was used as an EPS-producing strain control.  534 
 535 
Figure 2. Mean values (mM) of lactose consumption and production of lactic acid and 536 
acetic acid in milks fermented with EPS-producing Bifidobacterium and Lactobacillus 537 
strains from human origin at 37ºC during 17±1 h. The strain Streptococcus 538 
thermophilus ST-body-1, employed in yoghurt manufacture, was used as an EPS-539 
producing strain control. 540 
 541 
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